about
The biological and structural characterization of Mycobacterium tuberculosis UvrA provides novel insights into its mechanism of actionMutation K42R in ribosomal protein S12 does not affect susceptibility of Mycobacterium smegmatis 16S rRNA A-site mutants to 2-deoxystreptaminesGenetic reconstruction of protozoan rRNA decoding sites provides a rationale for paromomycin activity against Leishmania and TrypanosomaDNA alkylation damage as a sensor of nitrosative stress in Mycobacterium tuberculosisThe functions of OmpATb, a pore-forming protein of Mycobacterium tuberculosisLspA inactivation in Mycobacterium tuberculosis results in attenuation without affecting phagosome maturation arrestGenetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity.Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutantStabilization of the genome of the mismatch repair deficient Mycobacterium tuberculosis by context-dependent codon choice.Fitness cost of chromosomal drug resistance-conferring mutationsRecognition of potentially novel human disease-associated pathogens by implementation of systematic 16S rRNA gene sequencing in the diagnostic laboratory.Analysis of the contribution of individual substituents in 4,6-aminoglycoside-ribosome interactionMutations in 23S rRNA at the peptidyl transferase center and their relationship to linezolid binding and cross-resistance.Binding of neomycin-class aminoglycoside antibiotics to mutant ribosomes with alterations in the A site of 16S rRNA.Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycin.Identification of Gram-positive cocci by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry: comparison of different preparation methods and implementation of a practical algorithm for routine diagnostics.Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens.Practical approach for reliable detection of AmpC beta-lactamase-producing Enterobacteriaceae.Use of the Bruker MALDI Biotyper for identification of molds in the clinical mycology laboratoryUvrD2 is essential in Mycobacterium tuberculosis, but its helicase activity is not required.A statistical approach for determination of disk diffusion-based cutoff values for systematic characterization of wild-type and non-wild-type bacterial populations in antimicrobial susceptibility testing.Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobacterium tuberculosisEvaluation of the Bruker MALDI Biotyper for Identification of Fastidious Gram-Negative Rods.Important role for Mycobacterium tuberculosis UvrD1 in pathogenesis and persistence apart from its function in nucleotide excision repair.Engineering the rRNA decoding site of eukaryotic cytosolic ribosomes in bacteriaStructure-activity relationships among the kanamycin aminoglycosides: role of ring I hydroxyl and amino groupsA mycobacterial smc null mutant is proficient in DNA repair and long-term survival.Mitochondrial deafness alleles confer misreading of the genetic codePerformance of Copan WASP for Routine Urine Microbiology.Influence of clinical breakpoint changes from CLSI 2009 to EUCAST 2011 antimicrobial susceptibility testing guidelines on multidrug resistance rates of Gram-negative rodsTuberculosis drug resistance in an area of low endemicity in 2004 to 2006: semiquantitative drug susceptibility testing and genotyping.Tuberculosis: drug resistance, fitness, and strategies for global control.Characterization of the mycobacterial NER system reveals novel functions of the uvrD1 helicaseThe uracil DNA glycosylase UdgB of Mycobacterium smegmatis protects the organism from the mutagenic effects of cytosine and adenine deamination.Evaluation of the Bruker MALDI Biotyper for identification of Gram-positive rods: development of a diagnostic algorithm for the clinical laboratory.Phylogenetic sequence variations in bacterial rRNA affect species-specific susceptibility to drugs targeting protein synthesis.MASTER: a model to improve and standardize clinical breakpoints for antimicrobial susceptibility testing using forecast probabilities.Intrinsic rifamycin resistance of Mycobacterium abscessus is mediated by ADP-ribosyltransferase MAB_0591.Integrating forecast probabilities in antibiograms: a way to guide antimicrobial prescriptions more reliably?Drug susceptibility distributions in slowly growing non-tuberculous mycobacteria using MGIT 960 TB eXiST.
P50
Q27668076-2D444B40-DF08-4BD0-BA49-D24634DB8898Q28475020-F224F5C9-A208-490F-957A-1E2A694308CBQ28478249-CF8EB1F4-3FBB-4A2A-85D6-135BF50346EEQ28486985-79FD33C8-FF61-42D6-B10E-C394A136F5B8Q28487254-C859058D-949D-46BB-85F3-2964C8FC52F3Q28487560-9D106180-93C6-4FEB-B462-144C1BEA7B38Q30488706-67011CC7-0461-4D37-949E-958E461681B3Q30845265-0F4E094E-6790-4F6C-A733-B70D29723D62Q33338279-0BDAB06A-CF3B-4696-BD90-976B89F725DCQ34107494-F273F4D9-C300-41B1-BF52-B4EDAA6A26EDQ34120568-393E0E1E-921D-4448-AB07-CE04991D1E2EQ34228285-79064388-5B32-461B-8B17-EA52E95A32E1Q34289995-E65202BB-E6EB-4DAC-9E6B-6231E31AF1C9Q34510638-67B6656A-71A1-4A08-8AB7-9B30D9E243E2Q34631045-257E86F8-3BBA-49B6-89C5-72ED9080D6CBQ34647458-2835BF5B-9941-41AC-AA43-B462BAA687F4Q35066463-7C1126EC-9EA2-4343-8923-73EA6FFEB022Q35139767-B23305C9-2377-4516-B85B-DABE54BA23E7Q35172286-F43E8C49-BD6E-4BCA-95C2-F7472AD31F79Q35192088-A8655813-7120-41DA-A4EF-21CA90EFD519Q35607484-BD268193-61EB-4C33-9489-150A4D89BFEFQ35689424-4BA91B59-AC12-4DFF-A3E5-02ED0EF953B4Q35867204-F93F6A2D-21E2-4DD2-A447-99303494A3FCQ36018335-9186A71F-3FC1-4ACE-A1E1-0C1895732889Q36168675-8A3157EB-4E80-470D-94FE-FFD9AE198334Q36396224-32A9EA4B-7A95-4FCE-8238-D30D0E73D636Q36422288-6528941A-2B59-46F1-8973-FDCA7B78FAF3Q36491293-5EF77866-23C0-4F57-9A0F-A270D0D0E5B9Q36620942-4F5EB9A8-C8AF-4DAA-90B8-A0EC2BB2A980Q36971280-1E73D88A-563A-4FE9-B980-90BA4A253D0BQ36994443-97A5532C-CE4B-4514-A818-AFF29A2993B8Q36995218-92CF3A84-C77F-453E-A1A8-2691CFB9B434Q37051357-DC9157B5-E1CB-413B-9300-67188E4BB29CQ37365225-5E989298-D65C-499C-8D2A-01708977D135Q37713443-9E317DCC-5F48-4A82-9698-1ACC31FB279EQ38283201-D2FD3E7E-59E5-425F-BA1F-284A50C6974EQ38599564-56786185-5F61-402B-9B5E-DB7CCCED2F3EQ39080590-53D7AE2A-C2D7-4208-982E-4CD0ADB752A0Q39147849-62C493A9-2163-4889-A2D0-C66B585F6E7EQ39415872-153EAC6B-9421-4AE3-B855-0E9B7CDC1A44
P50
name
Erik C Böttger
@en
type
label
Erik C Böttger
@en
prefLabel
Erik C Böttger
@en